Industry Resources

Industry Resources

MBGH Reports

Transforming Pharmacy Benefits: The Role of Biosimilars, MBGH Report, June 2020

Precision Medicine in Pharmacy Design: Pharmacogenomics & Pharmacogenetics, MBGH, October 2020

Specialty Drug/PBM Reports

Shared Savings Demonstration for Biosimilars in Medicare: An Opportunity to Promote Biologic Drug Competition, Matrix Global Advisors, May 2020

IBM Watson Health Report: The importance of early key opinion leader outreach in the biologics and biosimilars marketplace, IBM Watson Health, July 2019

Carving Out Specialty Pharmacy and Using Biosimilars to Control Specialty Spend, Pfizer Vivio and Dean Foods, 2019

CVS Trends Report 2020 Highlights Upcoming Changes in Health Care Industry, Pharmacy Times, January 2020

CVS Specialty Pharmacy Pipeline, Drugs to Watch: Anticipated Launches Q4 2019 – Q1 2020

Prime Therapeutics Prime Insights: Give up on Biosimilars? Never!  February 20, 2020

Optum RxTrends to Watch in 2020

2019 Magellan Rx Management, Medical Pharmacy Trend Report (Tenth Edition)

PBMI Specialty Drug Benefits Reports – 2017, 2018, 2019  Registration required to access this report

PBMI Drug Benefits Reports – 2017, 2018 Registration required to access this report

2018 EMD Serono Specialty Digest (14th Edition)

Industry Reports

2020 Employer Rx Value, National Alliance of Healthcare Purchaser Coalitions

Medical Cost Trend: Behind the Numbers 2020, Health Research Institute, PwC

Global Medicine Spending and Usage Trends: Outlook to 2024, IQVIA Institute Report

Mercer’s 2019 National Survey of Employer-Sponsored Health Plans: Summary

2019 Willis Towers Watson Best Practices in Health Care Employer Survey: Targeting Specialty Drugs

2019 Economic Report on US Pharmacies and Pharmacy Benefit Managers, Pembroke Consulting

Global Oncology Trends 2019, IQVIA Institute Report

The Value of Biosimilars, Improving Treatment Access and Lowering Costs National Alliance, July 2018